C. Coleman

发表

Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses

S. Sarafianos, M. Frieman, S. Weiss, 2014, Antimicrobial Agents and Chemotherapy.

HIV-1 Nef Enhances Dendritic Cell-Mediated Viral Transmission to CD4+ T Cells and Promotes T-Cell Activation

C. Coleman, Li Wu, Corine St. Gelais, 2012, PloS one.

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

M. Frieman, G. Glenn, Gale Smith, 2014, Vaccine.

One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus

P. Jahrling, M. Frieman, L. Hensley, 2016, Journal of Virology.

Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection

M. Frieman, C. Coleman, Thiagarajan Venkataraman, 2017, Journal of Virology.

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

G. Olinger, J. Kuhn, E. Postnikova, 2016, Science Translational Medicine.

Growth and Quantification of MERS‐CoV Infection

M. Frieman, C. Coleman, 2015, Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.].

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.

Krystal L. Matthews, M. Frieman, C. Coleman, 2014, The Journal of general virology.

The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling.

Krystal L. Matthews, M. Frieman, Y. van der Meer, 2014, The Journal of general virology.

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

M. Frieman, G. Glenn, Gale Smith, 2017, Vaccine.

Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus 1 Infection

G. Olinger, P. Jahrling, Pamela J. Glass, 2014 .

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

G. Yancopoulos, Kristen E Pascal, N. Stahl, 2015, Proceedings of the National Academy of Sciences.

Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

M. Frieman, C. Coleman, Kirsten A. Kulcsar, 2019, JCI insight.

SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons

Baek Kim, J. Hollenbaugh, C. Coleman, 2012, Retrovirology.

The Anti-Apoptotic Effect of Respiratory Syncytial Virus on Human Peripheral Blood Neutrophils is Mediated by a Monocyte Derived Soluble Factor

M. Everard, C. Coleman, M. Whyte, 2011, The open virology journal.

Treating MERS-CoV during an outbreak

M. Frieman, C. Coleman, 2014, The Lancet Infectious Diseases.

Determining How Coronaviruses Overcome the Interferon and Innate Immune Response

C. Coleman, 2020, Methods in molecular biology.

Respiratory syncytial virus and persistent infection of dendritic cells.

M. Everard, C. Coleman, K. Plant, 2009, The Pediatric infectious disease journal.

Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

P. Gershkovich, C. Hayes, K. Mellits, 2021, Virulence.

Sustaining rotavirus vaccination in Africa: measuring vaccine eff ectiveness

M. Frieman, C. Coleman, 2014 .

Emergence of the Middle East Respiratory Syndrome Coronavirus

M. Frieman, V. Munster, C. Coleman, 2013, PLoS pathogens.

Coronaviruses: Important Emerging Human Pathogens

M. Frieman, C. Coleman, Christopher M. Coleman, 2014, Journal of Virology.

Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections.

W. Lim, P. Bath, A. Webb, 2021, F1000Research.

Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections

W. Lim, P. Bath, A. Webb, 2021, F1000Research.

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo

Krystal L. Matthews, M. Frieman, Yize Li, 2020, Journal of Virology.

SARS-CoV-2 in vitro and SARS-CoV in vivo

Krystal L. Matthews, M. Frieman, J. Logue, 2020 .

Retrovirology BioMed Central Review HIV interactions with monocytes and dendritic cells: viral latency and reservoirs

C. Coleman, Li Wu, Christopher M Coleman, 2009 .

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

Julie Dyall, Michael R. Holbrook, Peter B. Jahrling, 2014, Antimicrobial Agents and Chemotherapy.

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion

M. Frieman, Judith M. White, E. Nelson, 2016, Journal of Virology.

CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome

S. Rajagopalan, C. Kyratsous, Krystal L. Matthews, 2016, Journal of Virology.

Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference

Sandra Postel, Eric J. Sundberg, S. Postel, 2015, Journal of Virology.

Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells.

C. Coleman, Li Wu, C. S. Gelais, 2013, Advances in experimental medicine and biology.

Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef

P. Spearman, C. Coleman, Li Wu, 2011, Retrovirology.

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients

W. Dowling, K. Rosenke, C. Muñoz-Fontela, 2020, Nature Communications.

Growth and Quantification of MERS‐CoV Infection

M. Frieman, C. Coleman, 2015, Current protocols in microbiology.